ICU Medical, Inc.

Total Valuation

ICU Medical, Inc. carries a market capitalization of 4.18B, placing it among publicly traded companies globally. Its enterprise value stands at 4.64B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

ICU Medical, Inc. currently has 25.01M shares outstanding.

Valuation Ratios

ICU Medical, Inc. trades at a trailing price-to-earnings ratio of 120.75. The price-to-sales ratio is 1.68, and the price-to-book ratio stands at 1.70.

Enterprise Valuation

On an enterprise value basis, ICU Medical, Inc. trades at an EV/EBITDA multiple of 13.45 and an EV/FCF ratio of 1.23. The EV/Sales ratio of 2.15 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 32.27 provides insight into valuation relative to core operating earnings.

Financial Position

ICU Medical, Inc. maintains a current ratio of 2.43, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 59.09, indicating elevated leverage, while an interest coverage ratio of 4.20 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, ICU Medical, Inc. has paid -30.95M in income taxes, reflecting an effective tax rate of 30.55.

Stock Price Statistics

ICU Medical, Inc.'s stock has gained approximately 43.80428% over the past 52 weeks. The 50-day moving average sits at 167.98, while the 200-day moving average is 147.67.

Income Statement

Over the trailing twelve months, ICU Medical, Inc. generated 2.16B in revenue and converted that into 30.09M in net income, yielding earnings per share of 1.21. EBITDA reached 345.02M, while operating income came in at 143.75M.

Balance Sheet

ICU Medical, Inc. holds 298.30M in cash and equivalents against 1.27B in total debt, resulting in a net debt position of 932.90M. Total book value stands at 2.15B, with working capital of 712.54M providing operational flexibility.

Cash Flow

ICU Medical, Inc. produced 236.37M in operating cash flow over the past twelve months. After subtracting -91.52M in capital expenditures, free cash flow totaled 144.84M - equivalent to 5.84 per share.

Margins

ICU Medical, Inc. operates with a gross margin of 39.13, reflecting its pricing power and cost economics. The operating margin of 6.66 and net profit margin of 1.39 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

ICU Medical, Inc.'s most recent stock split took place on March 18, 2002 with a 2:3 split ratio.

Scores

ICU Medical, Inc. posts an Altman Z-Score of 3.57, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.